Gary, I have to admire your ongoing positive attitude and outlook over these years, especially in view of some significant health issues you've had to deal with. I'm almost your age and have remained pretty healthy for the most part but having accumulated shares in the company over the past 14 years I find myself getting more frustrated with the lack of information it provides. Maybe it's I've become increasing aware over the years that all of us (and that includes companies) are finite and should be judged on how effectively we used the time allotted to us, resulting in an increased lack of patience on my part.
The delay in the MHRA decision is frustrating, but I came to the conclusion months ago that the 2024 goal was just a goal, nothing more, and that the agency had failed to make any significant progress in cutting through large 2023 backlog, much less the subsequent 2024 one. That was substantiated by the recent December report confirming that, including staffing and funding problems. Well, we are dealing with a government agency, so expecting efficiency is unlikely.
The continued lack of any information on any EDEN progress is more a of a current concern to me. The company has had the technology for over 5 years and hasn't mentioned it for nearly a year. Progress on clean room aside, there hasn't been a mention of any progress on a working production unit for nearly a year, and that was only on the design. Checking my notes I believe they were considering had two possible approaches at that time, but be it one or two, why can't the company provide some information. Not looking for any secrets, just an update on progress. Even if the news isn't great, it shouldn't have a huge impact on the share price, which in mainly tied to the MLHRA decision.
News 
Market Data 
Markets 
AI
